1. Latest News
  2. Submit Press Release

Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets

This study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies in testing for genetic diseases, cancer, forensic and paternity/HLA applications.

YONKERS, N.Y. - July 25, 2014 - PRLog -- Venture Planning Group (http://www.vpgmarketresearch.com), an international publishing and management consulting firm, is pleased to announce completion of the new report, “Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape.” The study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

To review the Table of Contents and List of Tables, or to order this report, please visit:


Report Highlights

- Market shares of leading suppliers
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.

The molecular diagnostic testing market is the most rapidly growing segment of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.

The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Five-year test volume and sales projections:

- Infectious Diseases

- Cancer

- Genetic Diseases

- Forensic Testing

- Paternity Testing/HLA Typing

- Others

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of the major molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
   - Abbott
   - Affymetrix
   - Agilent Technologies
   - Applied Gene Technologies
   - Arca/Nuvelo
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biokit
   - BioMerieux
   - Bio-Rad
   - Biotest
   - Caliper
   - Cepheid
   - Decode
   - Diadexus
   - Eiken
   - Enzo
   - Exact Sciences
   - Fujirebio/Innogenetics
   - Grifols
   - Hologic/Gen-Probe
   - Illumina
   - Kreatech
   - Li-Cor Biosciences
   - Life Technologies/Thermo Fisher
   - Monogram Biosciences
   - Myriad Genetics
   - Nanogen/Elitech
   - Orchid CellMark
   - Ortho-Clinical Diagnostics
   - Proteome Sciences
   - Qiagen
   - Roche
   - Scienion
   - Sequenom
   - Shimadzu
   - Siemens
   - Sierra Molecular
   - Takara Bio
   - Tecan Group

- Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 570 pages and 42 tables

To order this report or review related Molecular Diagnostics market reports, please visit: http://www.vpgmarketresearch.com/Molecular-Diagnostics

For further details or questions regarding our reports, please contact:

Robert Fisher
+1 212 564 2838


Media Contact
Robert Fisher

--- End ---

Click to Share

Contact Email:
***@vpgcorp.com Email Verified
Source:Venture Planning Group
Location:Yonkers - New York - United States
Tags:Molecular Diagnostics
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share